Anti-SFRP4/ FRP-4/ FRPHE functional antibody

Anti-SFRP4/ FRP-4/ FRPHE functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to SFRP4/SFRP4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T93727-Ab-1/ GM-Tg-hg-T93727-Ab-2Anti-Human SFRP4 monoclonal antibodyHuman
GM-Tg-rg-T93727-Ab-1/ GM-Tg-rg-T93727-Ab-2Anti-Rat SFRP4 monoclonal antibodyRat
GM-Tg-mg-T93727-Ab-1/ GM-Tg-mg-T93727-Ab-2Anti-Mouse SFRP4 monoclonal antibodyMouse
GM-Tg-cynog-T93727-Ab-1/ GM-Tg-cynog-T93727-Ab-2Anti-Cynomolgus/ Rhesus macaque SFRP4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T93727-Ab-1/ GM-Tg-felg-T93727-Ab-2Anti-Feline SFRP4 monoclonal antibodyFeline
GM-Tg-cang-T93727-Ab-1/ GM-Tg-cang-T93727-Ab-2Anti-Canine SFRP4 monoclonal antibodyCanine
GM-Tg-bovg-T93727-Ab-1/ GM-Tg-bovg-T93727-Ab-2Anti-Bovine SFRP4 monoclonal antibodyBovine
GM-Tg-equg-T93727-Ab-1/ GM-Tg-equg-T93727-Ab-2Anti-Equine SFRP4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T93727-Ab-1/ GM-Tg-hg-T93727-Ab-2; GM-Tg-rg-T93727-Ab-1/ GM-Tg-rg-T93727-Ab-2;
GM-Tg-mg-T93727-Ab-1/ GM-Tg-mg-T93727-Ab-2; GM-Tg-cynog-T93727-Ab-1/ GM-Tg-cynog-T93727-Ab-2;
GM-Tg-felg-T93727-Ab-1/ GM-Tg-felg-T93727-Ab-2; GM-Tg-cang-T93727-Ab-1/ GM-Tg-cang-T93727-Ab-2;
GM-Tg-bovg-T93727-Ab-1/ GM-Tg-bovg-T93727-Ab-2; GM-Tg-equg-T93727-Ab-1/ GM-Tg-equg-T93727-Ab-2
Products NameAnti-SFRP4 monoclonal antibody
Formatmab
Target NameSFRP4
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SFRP4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T93727-Ag-1Recombinant multi-species SFRP4/ FRP-4/ FRPHE protein


    Target information

    Target IDGM-T93727
    Target NameSFRP4
    Gene ID6424,20379,89803,574393,483258,101100795,518004,100051069
    Gene Symbol and SynonymsFRP-4,FRPHE,FRZB-2,PYL,sFRP-4,SFRP4
    Uniprot AccessionQ6FHJ7,Q9JLS4,Q7YRN1
    Uniprot Entry NameSFRP4_HUMAN,SFRP4_MACMU,SFRP4_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000106483
    Target ClassificationTumor-associated antigen (TAA)

    The target: SFRP4, gene name: SFRP4, also named as FRP-4, FRPHE, FRZB-2, PYL, sFRP-4. Secreted frizzled-related protein 4 (SFRP4) is a member of the SFRP family that contains a cysteine-rich domain homologous to the putative Wnt-binding site of Frizzled proteins. SFRPs act as soluble modulators of Wnt signaling. The expression of SFRP4 in ventricular myocardium correlates with apoptosis related gene expression. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.